.

OracleBio & IQVIA Advance AI Digital Pathology in Clinical Trials
21 April 2026
By Mark Laurie

OracleBio is pleased to announce a collaboration with IQVIA Laboratories, a global leader in clinical research laboratory services, to integrate OracleBio’s AI-driven image analysis capabilities into IQVIA Laboratories’ digital pathology workflows. Through this collaboration, OracleBio will provide specialized services in AI-powered image analysis solutions, including algorithm development and validation supported by IQVIA Laboratories’ expert team of pathologists, along with a cloud-enhanced image analysis workflow to accelerate the access of robust data findings.

The collaboration brings together complementary expertise to support sponsors seeking deeper, more consistent insight from tissue-based endpoints in clinical trials. OracleBio’s expertise in development of specialised algorithms for quantitative analysis of whole slide images – including immune cell distribution, tumour microenvironment characterisation, and biomarker expression, will extend IQVIA Laboratories’ existing anatomic and digital pathology services. Working together further enables sponsors to provide their own algorithms developed using commercial platforms such as Indica Labs® and Visiopharm®, or through proprietary tools/scripts, which OracleBio can integrate into its clinical trial image analysis workflow for exploratory biomarker data endpoints.

Together, the two organisations aim to help sponsors generate richer pathology datasets that support biomarker discovery, patient stratification, and endpoint assessment with greater precision and reproducibility.

“This collaboration with IQVIA Laboratories is an exciting step for OracleBio. Clinical trials are generating increasingly complex tissue-based data, and sponsors need analytical solutions that are both scientifically rigorous and operationally seamless. By integrating our image analysis expertise into IQVIA Laboratories’ workflows, we can help sponsors extract meaningful insight from pathology data and make more informed development decisions.” – Lorcan Sherry, Chief Scientific Officer, OracleBio

Read the full announcement here.

📩 Newsletter: Subscribe now for the latest OracleBio news, direct to your inbox →

Find out about OracleBio's Pathology Expertise

Learn How OracleBio Can Support You

Speak to our experts

Planning your study and need advice on your image analysis? We’d love to chat!